These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 6270182

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of various neuropeptides on the secretion of proopiomelanocortin-derived peptides by a cultured pituitary adenoma causing Nelson's syndrome.
    Shibasaki T, Masui H.
    J Clin Endocrinol Metab; 1982 Nov; 55(5):872-6. PubMed ID: 6126487
    [Abstract] [Full Text] [Related]

  • 3. Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion.
    Allolio B, Winkelmann W, Hipp FX, Kaulen D, Mies R.
    J Clin Endocrinol Metab; 1982 Jul; 55(1):1-7. PubMed ID: 6281297
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of a met-enkephalin analogue and naloxone infusion on gonadotrophin secretion in man.
    Delitala G, Giusti M, Devilla L, Mazzocchi G, Lotti G, Giordano G.
    Acta Eur Fertil; 1981 Sep; 12(3):287-8. PubMed ID: 6803502
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. ACTH and beta-endorphin secretion by three corticotrophic adenomas in culture. Effects of culture time, dexamethasone, vasopressin and synthetic corticotrophin releasing factor.
    Oosterom R, Verleun T, Uitterlinden P, Hackeng WH, Burbach JP, Wiegant VM, Lamberts SW.
    Acta Endocrinol (Copenh); 1984 May; 106(1):21-9. PubMed ID: 6328819
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The met-enkephalin analog FK 33-824 directly inhibits ACTH release by the rat pituitary gland in vitro.
    Lamberts SW, Janssens EN, Bons EG, Uitterlinden P, Zuiderwijk JM, Del Pozo E.
    Life Sci; 1983 Mar 14; 32(11):1167-73. PubMed ID: 6300576
    [No Abstract] [Full Text] [Related]

  • 12. Probable ACTH-secreting pituitary tumour in association with Addison's disease.
    Yanase T, Sekiya K, Ando M, Nawata H, Kato K, Ibayashi H.
    Acta Endocrinol (Copenh); 1985 Sep 14; 110(1):36-41. PubMed ID: 2994336
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
    Lamberts SW, Verleun T, Oosterom R, de Jong F, Hackeng WH.
    J Clin Endocrinol Metab; 1984 Feb 14; 58(2):298-303. PubMed ID: 6319446
    [Abstract] [Full Text] [Related]

  • 15. Direct effects of thyrotropin-releasing hormone, cyproheptadine, and dopamine on adrenocorticotropin secretion from human corticotroph adenoma cells in vitro.
    Ishibashi M, Yamaji T.
    J Clin Invest; 1981 Oct 14; 68(4):1018-27. PubMed ID: 6270192
    [Abstract] [Full Text] [Related]

  • 16. In vitro effects of ketoconazole on corticotrope cell morphology and ACTH secretion of two pituitary adenomas removed from patients with Nelson's syndrome.
    Jimenez Reina L, Leal-Cerro A, Garcia J, Garcia-Luna PP, Astorga R, Bernal G.
    Acta Endocrinol (Copenh); 1989 Aug 14; 121(2):185-90. PubMed ID: 2549753
    [Abstract] [Full Text] [Related]

  • 17. Thyrotropin-releasing hormone stimulation of adrenocorticotropin production by mouse pituitary tumor cells in culture: possible model for anomalous release of adrenocorticotropin by thyrotropin-releasing hormone in some patients with Cushing's disease and Nelson's syndrome.
    Gershengorn MC, Arevalo CO, Geras E, Rebecchi MJ.
    J Clin Invest; 1980 Jun 14; 65(6):1294-300. PubMed ID: 6251109
    [Abstract] [Full Text] [Related]

  • 18. Plasma LH, FSH and TSH responses to the synthetic enkephalin analog (FK 33-824) in normal subjects and patients with pituitary diseases.
    Demura R, Suda T, Wakabayashi I, Ono M, Jibiki K, Odagiri E, Demura H, Shizume K.
    Tohoku J Exp Med; 1982 Jul 14; 137(3):283-7. PubMed ID: 6810504
    [Abstract] [Full Text] [Related]

  • 19. Effect of cyproheptadine, desmethylcyproheptadine, gamma-amino-butyric acid and sodium valproate on adrenocorticotrophin secretion by cultured pituitary tumour cells from three patients with Nelson's syndrome.
    Lamberts SW, Verleun T, Bons EG, Uitterlinden P, Oosterom R.
    J Endocrinol; 1983 Mar 14; 96(3):401-6. PubMed ID: 6300275
    [Abstract] [Full Text] [Related]

  • 20. Effects of valproic acid, naloxone and hydrocortisone in Nelson's syndrome and cushing's disease.
    Elias AN, Gwinup G, Valenta LJ.
    Clin Endocrinol (Oxf); 1981 Aug 14; 15(2):151-4. PubMed ID: 6273025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.